Close

FDA Approves ViiV Healthcare's Triumeq (GSK) (PFE)

August 22, 2014 2:25 PM EDT Send to a Friend
ViiV Healthcare announced today that the US Food and Drug Administration (FDA) has approved Triumeq® (abacavir 600mg, dolutegravir 50mg and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login